Ligand profile
MGW
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4295 — peptidase M16 inactive domain protein
Identifiers
Database identifiers and provenance.
- Ligand ID
MGW- PDB
4gsc- UniProt (similar protein)
P14735- Target protein
- VK055_4295
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 124.6
- −1 ≤ LogP ≤ 5 0.24
- MW ≤ 500 Da 388.4
- LogP ≤ 5 0.24
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 124.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COC(=O)[C@H](Cc1cnc[nH]1)NC(=O)C[N@@](CCc2ccccc2)CC(=O)OCOC(=O)[C@H](Cc1cnc[nH]1)NC(=O)C[N@@](CCc2ccccc2)CC(=O)O
InChI=1S/C19H24N4O5/c1-28-19(27)16(9-15-10-20-13-21-15)22-17(24)11-23(12-18(25)26)8-7-14-5-3-2-4-6-14/h2-6,10,13,16H,7-9,11-12H2,1H3,(H,20,21)(H,22,24)(H,25,26)/t16-/m0/s1InChI=1S/C19H24N4O5/c1-28-19(27)16(9-15-10-20-13-21-15)22-17(24)11-23(12-18(25)26)8-7-14-5-3-2-4-6-14/h2-6,10,13,16H,7-9,11-12H2,1H3,(H,20,21)(H,22,24)(H,25,26)/t16-/m0/s1
GGPUXIJTYUPCEL-INIZCTEOSA-NGGPUXIJTYUPCEL-INIZCTEOSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF05193' 'PF16187
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand MGW →
- PDB RCSB structure 4gsc →
- UniProt UniProt P14735 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “MGW”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4295.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 12
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).